I think they were up against walls on all fronts.
audiologists didn’t want to support a low margin device.
big box retailers didn’t want to offer in store point of sale or after sales support.
customers didn’t want oversized black plugs in their ears.
in hindsight there doesn’t appear to have been appropriate research and strategy, everything looks like a reactionary pivot, too late. Chasing fda was a mistake, especially without features that would allow an audiologist to adjust the devices and give be them a piece of the pie.
I do hope the strategic review is about getting the right expertise in to get the approach right, and not simply find an exit for far joy…
- Forums
- ASX - By Stock
- Ann: March 2024 Quarterly Appendix 4C
I think they were up against walls on all fronts.audiologists...
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUH (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NUH (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online